Vaxon Biotech

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

New At The Helm Company Changes AVNI , Yuval, MD To: Beta-O2 Technologies Ltd. , CEO (March) From: Giza VC, Partner Phone: +972 3 918 0700 BECKMAN , Richard, MD To: Unilife Corp. , SVP, CM

CEOs And Presidents Jeff Jonker has been named president of NGM Biopharmaceuticals, Inc. and David Woodhouse joins the company as chief financial officer. Prior to joining NGM, Jonker was the seni

At its first analyst day in three years on May 6, Celgene Corp. walked Wall Street through how it would double revenues by 2017 and reduce its long-standing reliance on Revlimid (lenalidomide).